Feasibility and clinical effectiveness of transjugular intrahepatic portosystemic shunt creation in pediatric and adolescent patients: a meta-analysis
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Mar 2022 · 1 min read
In brief
In brief
Meta-analysis of 286 pediatric patients demonstrates TIPS is highly feasible and effective for managing portal hypertension in children, with 95% technical success and 93% clinical success rates. Portosystemic gradient reduction from 21.5 to 8.3 mmHg and 100% secondary patency support TIPS as viable long-term management.
Written by the GCMD Library team from the article.
Abstract
Objective
Transjugular intrahepatic portosystemic shunt (TIPS) is a useful approach in managing complications caused by severe portal hypertension (PH) in adults. In children, TIPS is technically challenging, and previous studies of TIPS in children have yielded inconsistent results. This study aimed to elucidate the feasibility and clinical effectiveness of TIPS in pediatric and adolescent patients.
Methods
This meta-analysis study identified relevant publications through medical databases. The primary outcomes included technical success, hemodynamic success, and clinical success. The secondary outcomes were primary patency rate, shunt revision rate, and secondary patency rate.
Results
A total of 286 patients representing 13 studies were eligible for analysis. The pooled rates of technical success, hemodynamic success, and clinical success were 95% (95% CI 88–99), 89% (95% CI 81–95), and 93% (95% CI 86–98), respectively. The portosystemic gradient decreased from 21.5 mmHg before TIPS to 8.3 mmHg after TIPS. The pooled estimates of primary patency rate, shunt revision rate, and secondary patency rate were 84% (95% CI 72–94), 35% (95% CI 21–51), and 100% (95% CI 92–100), respectively.
Conclusion
Study results suggest that TIPS may be feasible and effective in children with PH of various etiologies as for long-term management.